Literature DB >> 12580907

Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort.

C Sengler1, A Haider, C Sommerfeld, S Lau, M Baldini, F Martinez, U Wahn, R Nickel.   

Abstract

BACKGROUND: Multiple genetic studies have shown linkage of atopy-related phenotypes to chromosome 5q31. In this region several candidate genes for atopy are localized such as the Th2 cytokines IL-4, IL-5 and IL-13, but also CD14, a receptor for LPS. Recently, a functional CD14 promoter polymorphism was related to total and specific IgE responsiveness.
OBJECTIVE: The aim of our study was to evaluate the role of this single nucleotide polymorphism (SNP) in a large German birth cohort.
METHODS: Atopy-related phenotypes were longitudinally carefully evaluated in over 800 children from birth to the age of 10 years. Yearly visits included standardized interviews, physical examinations and determination of total and specific IgE antibodies. Pulmonary function tests and histamine provocations were performed at the age of seven. Eight-hundred and seventy-two children of the Multicenter Allergy Study (MAS) cohort were genotyped using melting curve and restriction digest analyses.
RESULTS: CD14-159 allele frequencies were consistent with previous reports, however, no association of the SNP with asthma, atopic dermatitis, allergic rhinitis, total or specific IgE levels could be observed.
CONCLUSION: The CD14-159 SNP might not play a major role in the development of atopy in German children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580907     DOI: 10.1046/j.1365-2222.2003.01549.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  33 in total

1.  Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations.

Authors:  Mamta Sharma; Jyotsna Batra; U Mabalirajan; Sangeeta Goswami; Dipyaman Ganguly; Brajen Lahkar; N K Bhatia; Amrendra Kumar; Balaram Ghosh
Journal:  Immunogenetics       Date:  2004-09-18       Impact factor: 2.846

2.  No Association Between -159C/T Polymorphism of the CD14 Gene and Asthma Risk: a Meta-Analysis of 36 Case-Control Studies.

Authors:  Rui Zhang; Rui Deng; He Li; Hong Chen
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 3.  Gene-environment interactions in asthma.

Authors:  S McLeish; S W Turner
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

4.  Association of CD14 gene -159C/T polymorphism with allergic rhinitis risk: a meta-analysis.

Authors:  Yu Xu; Jun Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-30       Impact factor: 2.503

5.  Association of CD14/-260 polymorphism with gastric cancer risk in Highland Tibetans.

Authors:  Kang Li; Zeng Dan; Xue-Jun Hu; Luo-Bu Gesang; Yong-Ge Ze; Zha-Xi Bianba; Cuo-Mu Ciren; Yu-Qiang Nie
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 6.  The role of endotoxin and its receptors in allergic disease.

Authors:  L Keoki Williams; Dennis R Ownby; Mary J Maliarik; Christine C Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2005-03       Impact factor: 6.347

Review 7.  The genetics of atopic dermatitis: recent findings and future options.

Authors:  Sabine Hoffjan; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2005-05-18       Impact factor: 4.599

8.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 9.  The genetics of atopic dermatitis.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

10.  CD14 C-159T and toll-like receptor 4 Asp299Gly polymorphisms in surviving meningococcal disease patients.

Authors:  Ariane Biebl; Axel Muendlein; Zhyrgal Kazakbaeva; Sigrid Heuberger; Gudrun Sonderegger; Heinz Drexel; Susanne Lau; Renate Nickel; Michael Kabesch; Burkhard Simma
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.